Jump to ContentJump to Main Navigation
The Handbook of Mergers and Acquisitions$
Users without a subscription are not able to see the full content.

David Faulkner, Satu Teerikangas, and Richard J. Joseph

Print publication date: 2012

Print ISBN-13: 9780199601462

Published to Oxford Scholarship Online: September 2012

DOI: 10.1093/acprof:oso/9780199601462.001.0001

Show Summary Details
Page of

PRINTED FROM OXFORD SCHOLARSHIP ONLINE (www.oxfordscholarship.com). (c) Copyright Oxford University Press, 2017. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a monograph in OSO for personal use (for details see http://www.oxfordscholarship.com/page/privacy-policy).date: 23 March 2018

Characteristics of Biotechnology Mergers and Acquisitions

Characteristics of Biotechnology Mergers and Acquisitions

(p.638) Chapter 26 Characteristics of Biotechnology Mergers and Acquisitions
The Handbook of Mergers and Acquisitions

Lars Schweizer

Oxford University Press

This chapter deals with the characteristics of biotechnology mergers and acquisitions (M&As). Analysis of the development of the biotechnology industry from scientific and organizational perspectives leads to the conclusion that a strategic consolidation in the biotechnology industry will take place. M&A activities in the biotechnology industry are driven by the motive to internationalize research and development, to take part in the industry’s development process, as well as to realize the biotech firm’s growth strategy. A successful post-acquisition integration of biotechnology M&A deals requires careful consideration of culture, people, and organizational integration. The latter deals in particular with the experience effect, knowledge transfer, and the question of how to measure M&A success. Especially pharmaceutical companies need to apply a hybrid post-acquisition integration approach, with simultaneous short- and long-term motives/orientations and segmentation at a different pace across different value-chain components in order to successfully integrate an acquired biotechnology firm.

Keywords:   M&A, biotechnology, strategy, post-acquisition integration, cultural integration, people integration, organizational integration, knowledge transfer

Oxford Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.

Please, subscribe or login to access full text content.

If you think you should have access to this title, please contact your librarian.

To troubleshoot, please check our FAQs , and if you can't find the answer there, please contact us .